Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REVISIT: ATM-AVI for Serious Gram-Negative Infections
NCT03329092Phase 3Completed
- Sponsor
- Pfizer
- Start
- Apr 2018
- Primary completion
- Feb 2023
- Modality
- Covalent Small Molecules
- Countries
- 21
01
Overview
A Phase 3 trial of aztreonam + avibactam in Intra-abdominal infection (IAI), hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP), sponsored by Pfizer. Started Apr 2018; status: completed.
02
Drugs
aztreonam + avibactam
03
Conditions
Intra-abdominal infection (IAI)hospital-acquired pneumonia (HAP)ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT03329092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03329092.